Nav: Home

News from Dec. 23, 2014, Annals of Internal Medicine

December 22, 2014

1. Blood pressure drugs likely to prevent stroke and death in patients with mild hypertension

Pharmacologic blood pressure reduction may prevent major cardiovascular events and death in patients with mild, or stage 1 hypertension (systolic blood pressure of 140 to 159 mm Hg and/or diastolic blood pressure of 90 to 99 mm Hg), according to a systematic review published in Annals of Internal Medicine. Having elevated blood pressure is the leading cause of premature death globally and the number of persons with clinically abnormal blood pressure is increasing. Most of these patients have mild hypertension and no overt cardiovascular disease and the effects of pharmacologic blood pressure reduction in this group are unclear. Researchers conducted a systematic review of published evidence to determine whether pharmacologic blood pressure reduction prevents cardiovascular events and deaths in persons with mild hypertension. They found that blood pressure-lowering therapy tended to lead to reductions in stroke, cardiovascular deaths, and total deaths.

Note: The URL for this story will be live when embargo lifts. For a PDF, please contact Megan Hanks. To interview Dr. Johan Sundström, please contact Maria Åslund at or +46 18 611 95 44.

2. Task force reviews evidence to update blood pressure screening recommendations

Ambulatory monitoring may improve the diagnostic accuracy of office screening

Repeated measurements taken outside of a medical setting by ambulatory blood pressure monitoring may improve the diagnostic accuracy of blood pressure screening conducted in a clinical setting, according to an evidence review published in Annals of Internal Medicine. Nearly one in three U.S. adults has high blood pressure, the leading risk factor for premature death. Previous evidence reviews have shown that treatment of adults with high blood pressure can reduce cardiovascular disease events. Researchers for the U.S. Preventive Services Task Force (USPSTF) reviewed published studies to update a systematic review on the benefits and harms of screening for high blood pressure in adults. The researchers also summarized evidence on rescreening intervals and diagnostic and predictive accuracy of different blood pressure screening methods for cardiovascular events. Ambulatory blood pressure monitoring should be considered a reference standard for confirming elevated office blood pressure screening results to avoid misdiagnosis and overtreatment, unless immediate treatment is required. In addition, the review suggests that certain high-risk people should be screened more often than those without risk factors, and that there is a need for improving the accuracy of blood pressure measurement in the clinic. A draft recommendation statement will be posted for public comment at the USPSTF web site at when the embargo lifts.

Note: The URL will be live when the embargo lifts. For a PDF, please contact Megan Hanks. To interview the author of the evidence review, please contact Mary Sawyers at To interview a member of the Task Force, please contact Ana Fullmer or Nicole Raisch at

American College of Physicians

Related Blood Pressure Articles:

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.
Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.
The Lancet Neurology: High blood pressure and rising blood pressure between ages 36-53 are associated with smaller brain volume and white matter lesions in later years
A study of the world's oldest, continuously-studied birth cohort tracked blood pressure from early adulthood through to late life and explored its influence on brain pathologies detected using brain scanning in their early 70s.
Blood pressure control is beneficial, is it not?
Until recently, physicians had generally assumed that older adults benefit from keeping their blood pressure below 140/90 mmHg.
The 'blue' in blueberries can help lower blood pressure
A new study published in the Journal of Gerontology Series A has found that eating 200g of blueberries every day for a month can lead to an improvement in blood vessel function and a decrease in systolic blood pressure in healthy people.
More Blood Pressure News and Blood Pressure Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...